Medical Stocks

Cardinal Health Inc Valuation – January 2019 $CAH

Company Profile (excerpt from Reuters): Cardinal Health, Inc., incorporated on May 16, 1979, is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Company provides solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices across the world. As of June 30, 2016, the Company has manufactured or sourced approximately 2.8 billion individual consumer healthcare, home medical equipment and over-counter products, and served approximately 25,000 pharmacies.

 

Downloadable PDF version of this valuation:

ModernGraham Valuation of CAH – January 2019

Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?

What kind of Intelligent Investor are you?

Defensive Investor; must pass 6 out of the following 7 tests.
1. Adequate Size of the Enterprise Market Cap > $2Bil $14,614,005,822 Pass
2. Sufficiently Strong Financial Condition Current Ratio > 2 1.06 Fail
3. Earnings Stability Positive EPS for 10 years prior Pass
4. Dividend Record Dividend Payments for 10 years prior Pass
5. Earnings Growth Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end 22.78% Fail
6. Moderate PEmg Ratio PEmg < 20 14.79 Pass
7. Moderate Price to Assets PB Ratio < 2.5 OR PB*PEmg < 50 2.54 Pass
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor.
1. Sufficiently Strong Financial Condition Current Ratio > 1.5 1.06 Fail
2. Sufficiently Strong Financial Condition Debt to NCA < 1.1 5.76 Fail
3. Earnings Stability Positive EPS for 5 years prior Pass
4. Dividend Record Currently Pays Dividend Pass
5. Earnings Growth EPSmg greater than 5 years ago Pass

 

Stage 2: Determination of Intrinsic Value

EPSmg $3.32
MG Growth Estimate 2.20%
MG Value $42.80
Opinion Overvalued
MG Grade C
MG Value based on 3% Growth $48.08
MG Value based on 0% Growth $28.19
Market Implied Growth Rate 3.15%
Current Price $49.05
% of Intrinsic Value 114.61%

Cardinal Health Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years. The Enterprising Investor has concerns regarding the level of debt relative to the current assets. As a result, all value investors following the ModernGraham approach should explore other opportunities at this time or proceed cautiously with a speculative attitude.

As for a valuation, the company appears to be Overvalued after growing its EPSmg (normalized earnings) from $2.89 in 2015 to an estimated $3.32 for 2019. This level of demonstrated earnings growth does not support the market’s implied estimate of 3.15% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value below the price.

At the time of valuation, further research into Cardinal Health Inc revealed the company was trading above its Graham Number of $44.21. The company pays a dividend of $1.86 per share, for a yield of 3.8%, putting it among the best dividend paying stocks today. Its PEmg (price over earnings per share – ModernGraham) was 14.79, which was below the industry average of 52.7, which by some methods of valuation makes it one of the most undervalued stocks in its industry. Finally, the company was trading above its Net Current Asset Value (NCAV) of $-31.55.

Cardinal Health Inc receives an average overall rating in the ModernGraham grading system, scoring a C.

Stage 3: Information for Further Research

Net Current Asset Value (NCAV) -$31.55
Graham Number $44.21
PEmg 14.79
Current Ratio 1.06
PB Ratio 2.54
Current Dividend $1.86
Dividend Yield 3.80%
Number of Consecutive Years of Dividend Growth 20

Useful Links:

ModernGraham tagged articles Morningstar
Google Finance MSN Money
Yahoo Finance Seeking Alpha
GuruFocus SEC Filings

Most Recent Balance Sheet Figures

Balance Sheet Information 9/1/2018
Total Current Assets $24,445,000,000
Total Current Liabilities $23,057,000,000
Long-Term Debt $7,999,000,000
Total Assets $40,011,000,000
Intangible Assets $12,093,000,000
Total Liabilities $34,098,000,000
Shares Outstanding (Diluted Average) 306,000,000

Earnings Per Share History

EPS History
Next Fiscal Year Estimate $4.43
Jun2018 $0.81
Jun2017 $4.03
Jun2016 $4.32
Jun2015 $3.62
Jun2014 $3.38
Jun2013 $0.97
Jun2012 $3.06
Jun2011 $2.72
Jun2010 $1.77
Jun2009 $3.18
Jun2008 $3.57
Jun2007 $4.77
Jun2006 $2.33
Jun2005 $2.41
Jun2004 $3.35
Jun2003 $3.03
Jun2002 $2.33
Jun2001 $1.85
Jun2000 $1.58
Jun1999 $1.12

Earnings Per Share – ModernGraham History

EPSmg History
Next Fiscal Year Estimate $3.32
Jun2018 $2.92
Jun2017 $3.73
Jun2016 $3.41
Jun2015 $2.89
Jun2014 $2.48
Jun2013 $2.13
Jun2012 $2.76
Jun2011 $2.81
Jun2010 $2.94
Jun2009 $3.44
Jun2008 $3.47
Jun2007 $3.34
Jun2006 $2.65
Jun2005 $2.74
Jun2004 $2.74
Jun2003 $2.29

Recommended Reading:

Other ModernGraham posts about the company

Best Dividend Paying Stocks for Dividend Growth Investors – August 2018
10 Low PE Stock Picks for the Defensive Investor – August 2018
5 Undervalued Companies for the Defensive Investor Near 52 Week Lows – August 2018
10 Undervalued Companies for the Defensive Dividend Stock Investor – July 2018
Best Dividend Paying Stocks for Dividend Growth Investors – June 2018

Other ModernGraham posts about related companies

Zimmer Biomet Holdings Inc Valuation – January 2019 $ZBH
Henry Schein Inc Valuation – January 2019 $HSIC
Medtronic PLC Valuation – January 2019 $MDT
UnitedHealth Group Inc Valuation – November 2018 $UNH
Luminex Corp Valuation – October 2018 $LMNX
LHC Group Inc Valuation – September 2018 $LHCG
Chartwell Retirement Residences Valuation – August 2018 $TSE:CSH.UN
STERIS PLC Valuation – August 2018 $STE
CryoLife Inc Valuation – August 2018 $CRY
Charles River Laboratories International Inc Valuation – August 2018 $CRL

Disclaimer:

The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back To Top